APA (7th ed.) Citation

KL, K., H, A., P, K., MS, B., N, N., CL, E., . . . P, S. (2026). A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 32(1), 106. https://doi.org/10.1158/1078-0432.CCR-25-2763

Chicago Style (17th ed.) Citation

KL, Knutson, et al. "A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 32, no. 1 (2026): 106. https://doi.org/10.1158/1078-0432.CCR-25-2763.

MLA (9th ed.) Citation

KL, Knutson, et al. "A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 32, no. 1, 2026, p. 106, https://doi.org/10.1158/1078-0432.CCR-25-2763.